Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 11.09 is in line with its 5-year average of 11.89, near the low end of its 5-year range (1.90–41.98).
As of the fiscal period ended Tuesday, June 30, 2026. 22.48% above its 12-month average of 9.06.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.09.
CURRENT RATIO
11.09
CURRENT RATIO AVG TTM
9.06
CURRENT RATIO AVG 3Y
9.96
CURRENT RATIO AVG 5Y
11.89
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+22.48%
CURRENT VS 3Y AVG
+11.40%
CURRENT VS 5Y AVG
-6.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+195.77%
vs the sector median at left
Market Cap
$1.33B
Current Ratio
35.85
TTM Avg
18.03
3Y Avg
18.03
5Y Avg
18.03
Market Cap
$1.22B
Current Ratio
13.19
TTM Avg
12.35
3Y Avg
12.19
5Y Avg
16.27
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Tau Medical Ltd (DRTS) | $1.31B | 11.09 | 9.06 | 9.96 | 11.89 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.33B | 35.85 | 18.03 | 18.03 | 18.03 |
| Omeros Corporation (OMER)vs › | $1.34B | 1.95 | 2.22 | 2.95 | 3.45 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | 5.07 | 3.94 | 5.82 | 5.62 |
| Omada Health (OMDA)vs › | $1.23B | 3.91 | 2.85 | 3.60 | 3.60 |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | 1.20 | 1.17 | 1.13 | 1.04 |
| Cronos Group Inc. (CRON)vs › | $1.22B | 16.18 | 19.21 | 18.77 | 16.93 |
| Kardigan, Inc. (KARD)vs › | $1.22B | 8.72 | 9.20 | 9.20 | 9.20 |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.22B | 13.19 | 12.35 | 12.19 | 16.27 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.39B | N/A | N/A | N/A | N/A |
Current Ratio
11.09
Quick Ratio
11.09
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 11.09 |
| 2026-03-31 | 7.79 |
| 2025-12-31 | 7.45 |
| 2025-09-30 | 8.43 |
| 2025-06-30 | 10.52 |
| 2025-03-31 | 5.81 |
| 2024-12-31 | 7.40 |
| 2024-09-30 | 10.99 |
| 2024-06-30 | 11.66 |
| 2024-03-31 | 11.60 |
| 2023-12-31 | 12.07 |
| 2023-09-30 | 14.66 |
| 2023-06-30 | 17.74 |
| 2023-03-31 | 18.96 |
| 2022-12-31 | 24.55 |
| 2022-09-30 | 33.20 |
| 2022-06-30 | 41.98 |
| 2022-03-31 | 17.66 |
| 2021-12-31 | 7.41 |
| 2021-09-30 | 1.90 |
| 2021-06-30 | 18.21 |
| 2021-03-31 | 10.16 |
| 2020-12-31 | 22.73 |
| 2020-09-30 | 22.73 |
| 2020-06-30 | 22.73 |
| 2020-03-31 | 53.89 |
| 2019-12-31 | 22.11 |
| 2019-09-30 | 22.11 |
| 2019-06-30 | 22.11 |
| 2019-03-31 | 22.11 |
